This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: David Gordon Clarkson Breckenridge: Innovator in Liver Disease Treatment
Introduction
David Gordon Clarkson Breckenridge is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. With a total of 2 patents, Breckenridge is recognized for his innovative approaches to healthcare.
Latest Patents
Breckenridge's latest patents focus on methods of treating liver disease. The first patent discloses a method of preventing and/or treating liver disease by administering an ACC inhibitor in combination with an FXR agonist to a patient in need thereof. The second patent also addresses liver disease treatment, detailing a method that involves administering an ASK1 inhibitor in combination with an FXR agonist to a patient in need thereof. These patents highlight his commitment to advancing medical treatments.
Career Highlights
Breckenridge is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His work at Gilead has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in liver disease treatment.
Collaborations
Some of his notable coworkers include Jamie Geier Bates and John T Liles. Their collaboration has likely fostered an environment of innovation and shared expertise, further enhancing the impact of their work.
Conclusion
David Gordon Clarkson Breckenridge is a distinguished inventor whose work in liver disease treatment is paving the way for new therapeutic options. His patents and career at Gilead Sciences, Inc. reflect his dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile